Screening and management of portal hypertension in advanced hepatocellular carcinoma: a French practice survey.
Fiche publication
Date publication
novembre 2022
Journal
Clinics and research in hepatology and gastroenterology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr MANFREDI Sylvain
Tous les auteurs :
Allaire M, Manfredi S, Lerosey L, Ganne-Carrié N, Thabut D
Lien Pubmed
Résumé
Portal hypertension (PHT) and hepatocellular carcinoma (HCC) are two major complications of cirrhosis that are closely linked and impact patients prognosis, particularly acute variceal bleeding (AVB). Therefore, PHT screening and AVB prophylaxis are major issues to improve the outcome of the patients, but practices may vary among physicians.
Mots clés
Hepatocellular carcinoma, portal hypertension, prophylaxis
Référence
Clin Res Hepatol Gastroenterol. 2022 11 28;:102059